Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin.

scientific article published in June 2006

Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16785129

P50authorLuchino ChessaQ56240965
P2093author name stringPatrizia Farci
Cinzia Balestrieri
Cristiana Cauli
Maria Eliana Lai
Giancarlo Serra
Rosetta Scioscia
P433issue6 Suppl
P921main subjectchronic hepatitis CQ55779873
autoimmune hemolytic anemiaQ28814
peginterferon alfa-2aQ420056
ribavirinQ421862
P304page(s)ECR26
P577publication date2006-06-01
P1433published inHaematologicaQ5638209
P1476titleSevere autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin
P478volume91

Reverse relations

cites work (P2860)
Q33424591Autoimmune hemolytic anemia in treatment-naive chronic hepatitis C infection: a case report and review of literature
Q37118531Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review
Q33161405Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient
Q27490427Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection
Q35920339Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms
Q41600113Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report

Search more.